EBD GmbH is part of the KNect365 of Informa PLC


This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa
 
BIO-Europe 2015 BIO EBD Group
Share/Follow Us
Share this:
Follow this event:

BIO-Europe® Press Releases

News for BIO-Europe® 2016 will be available soon.

November 16, 2015BIO-Europe® 2015 in Munich sets record for attendance and partnering productivity Munich, Germany was the center of dealmaking activity in the life science industry during BIO-Europe® 2015. Held at Munich's International Congress Center from November 2–4, the event broke all previous records for attendance and partnering productivity. The event brought 3,520 executives from 1,886 companies and 55 countries, who engaged in over 19,000 one-to-one meetings t...  more ►

October 26, 2015BIO-Europe® 2015 is a virtual barometer of drug development future marketAn estimated 4,000 licensing opportunities to be on offer at event
BIO-Europe® 2015 international life science partnering conference, held in Munich, Germany, November 2–4, 2015, expects over 3,300 delegates representing investors, biotech innovators and pharmaceutical executives from the global drug development industry. "BIO-Europe is a valuable forum for us to meet a wide range of companies," said Jeremy Springhorn, PhD, Partner, Cor...  more ►

October 1, 2015Top life science industry executives will lead the BIO-Europe® 2015 programTopics address strategy shift in drug development approaches in recent years
The program of the BIO-Europe® 2015 international life science partnering conference, organized by EBD Group and held in Munich, Germany, November 2–4, 2015, is already packed with recognizable names and thought leaders from the global drug development industry. The opening plenary on Monday, November 2, takes a discerning look at the way big pharma companies are reconfig...  more ►

July 29, 2015European Technology Platform for Nanomedicine and ENATRANS European Consortium Launch the 2nd edition of the Nanomedicine Award The European Technology Platform for Nanomedicine (ETPN) and the EU-funded consortium, ENATRANS, have launched the second edition of the Nanomedicine Award to honor the best international nanomedicine innovations for 2015. The goal of the Award is to promote and reward...  more ►

July 7, 2015BIO-Europe® 2015 in Munich to take place November 2–4, 2015
Event expected to bring over 3,300 life science dealmakers to Bavaria
The twenty-first annual BIO-Europe® international life science partnering conference will be held in Munich, Germany, November 2–4, 2015. Organized by EBD Group, the event is co-hosted by BioM Biotech Cluster Development, the Bavarian Ministry of Economic Affairs and Media, Energy and Technology, and Cluster Biotechnology Bavaria. Bavaria is an ideal location because it ...  more ►

April 17, 2015Spotlight on Munich Business Facts Munich is home to a broad spectrum of high-capacity industries including life sciences; information and communication technology; automotive; aerospace; financial services; cross-industry technologies; skilled crafts; media/creative industries and corporate services. Munich is a growing city. The City of Munich has 1.46 million inhabitants (2013) and expects to grow to 1.65 ...  more ►


partnering360® Blog

April 29, 2016 Digital Health: Still a brave new world At this year’s BIO-Europe Spring® panel on “The Convergence of Therapeutics and Digital Health,” two panelists from big pharma joined two from Scandinavian digital health companies, agreeing that while the platform for digital health technologies is strong in Europe, much... more ►

April 19, 2016 The characteristics of a “winning” biotech startup QureTech Bio AB, a startup developing first line drugs to combat antibiotic resistance and infectious diseases, won the Start-up Slam: Sweden biotech competition at BIO-Europe Spring® 2016 in Stockholm, Sweden earlier this month. QureTech Bio AB participated in the pitching competition sponsored by... more ►

April 5, 2016 Images of BIO-Europe Spring® 2016 in Stockholm [See image gallery at www.partnering360.com] more ►

April 5, 2016 BIO-Europe Spring® 2016 Monday recap BIO-Europe Spring® 2016 kicked off in Stockholm, Sweden yesterday with a full program and hundreds of partnering meetings.   Morning workshops ranged from new partnerships and market access to precision medicine and vaccine development.   Mid-morning, the Stockholm Business Region... more ►

April 2, 2016 Is it possible to create new business out of clinical needs? Guest post by Björn Varnestig, CEO, Flemingsberg Science   During a period of three years, we let a group of experienced business developers (we call them business architects) walk the corridors of the Karolinska University Hospital, talking to people about the problems, needs and... more ►



partnering360:Insight Latest headlines from partnering360:Insight

April 28, 2016 PledPharma seeks partner for lead therapy Jacques Näsström, CEO of PledPharma, chats with Sten Stovall about the company’s current hunt for licensing partners for lead product PledOx (calmangafodipir). more ►

April 28, 2016 Affibody CEO describes three-year growth plan Affibody CEO David Bejker discusses the biotech's four key drug and diagnostic development programs and future plans for growing the company's portfolio of antibody mimetics. more ►

April 28, 2016 New VC bioqube on open innovation roots and investments targets Nico Vandervelpen, managing partner and co-founder of bioqube ventures, and Informa Pharma Intelligence's Mike Ward discuss the young venture capital firm's big plans for the future. more ►

April 28, 2016 QureTech Bio explains novel approach to antibiotic development CEO of QureTech Bio Dr. Fritiof Pontén explains how his company's novel class of antibacterial agents might help provide a solution to the current global crisis of antibiotic resistance. more ►

April 28, 2016 CEVEC CEO talks US deals to expand business CEVEC chief Frank Ubags speaks with Scrip's Lucie Ellis about how the platform technology company is enabling gene therapy companies to move their products into large scale clinical trials. more ►



Arrow Up

Follow this event:
Sign up now
For news and updates

Privacy Policy and Cookies Terms of Use

Home | Contact Us | Site Map
See more upcoming conferences ►

EBD Group's Family of Events

© 2009–2016 EBD GmbH
Privacy Policy and Cookies
Terms of Use